MedPath
NMPA Approval

Dapagliflozin Tablets

国药准字H20253933

April 15, 2025

Drug Information

达格列净片

片剂

5mg (按C₂₁H₂₅ClO₆计)

化学药品

April 15, 2025

Company Information

Applicant Company

吉林省梅河口市爱民东大街1088号

Manufacturing Company

南京市江北新区科创大道18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达格列净片 - NMPA 批准文号 | MedPath